| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ImmunoGen, Inc. | SVP & CHIEF LEGAL OFFICER | Common Stock | 0 | $0 | $29.30 | 12 Feb 2024 | Direct |
| ImmunoGen, Inc. | SVP & CHIEF LEGAL OFFICER | Restricted Stock Unit | 0 | $0 | $29.30 | 12 Feb 2024 | Direct |
| ImmunoGen, Inc. | SVP & CHIEF LEGAL OFFICER | Stock Option (Right to Buy) | 0 | $0 | $5.19 | 12 Feb 2024 | Direct |
| Evelo Biosciences, Inc. | General Counsel | Stock Option (Right to Buy) | 40,000 | 19 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMGN | ImmunoGen, Inc. | 12 Feb 2024 | 3 | $0 | 4 | SVP & CHIEF LEGAL OFFICER | 12 Feb 2024, 16:36 |
| IMGN | ImmunoGen, Inc. | 01 Feb 2024 | 1 | $0 | 4 | SVP & CHIEF LEGAL OFFICER | 05 Feb 2024, 21:28 |
| IMGN | ImmunoGen, Inc. | 30 Nov 2022 | 1 | +$2,076,000 | 4 | SVP & CHIEF LEGAL OFFICER | 30 Nov 2022, 16:16 |
| IMGN | ImmunoGen, Inc. | 21 Nov 2022 | 0 | $0 | 3 | SVP & CHIEF LEGAL OFFICER | 30 Nov 2022, 16:13 |
| EVLO | Evelo Biosciences, Inc. | 19 Jul 2022 | 1 | $0 | 4 | General Counsel | 14 Oct 2022, 16:37 |
| EVLO | Evelo Biosciences, Inc. | 19 Jan 2022 | 1 | $0 | 4 | General Counsel | 21 Jan 2022, 16:00 |